Randomized Comparison of Paclitaxel-Eluting Balloon and Stenting Versus Plain Balloon Plus Stenting Versus Directional Atherectomy for Femoral Artery Disease (ISAR-STATH)

Circulation

Volumn 135, Issue 23, 2017, Pages 2218-2226

  Ott, Ilka ^a   Cassese, Salvatore ^a   Groha, Philipp ^a   Steppich, Birgit ^a   Hadamitzky, Martin ^a   Ibrahim, Tareq ^b   Kufner, Sebastian ^a   Dewitz, Karl ^a   Hiendlmayer, Regina ^a   Laugwitz, Karl Ludwig ^b,c   Schunkert, Heribert ^a,c   Kastrati, Adnan ^a,c   Fusaro, Massimiliano ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Drug eluting balloon; Peripheral arterial disease

Indexed keywords

AGED; ANGIOGRAPHY; ARTICLE; BALLOON; BLOOD VESSEL PERFORATION; CAUSE OF DEATH; CLINICAL OUTCOME; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIRECTIONAL ATHERECTOMY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GUIDE WIRE; HEMORRHAGIC SHOCK; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PACLITAXEL ELUTING BALLOON; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; RETROPERITONEAL HEMORRHAGE; SMOKING; TARGET LESION REVASCULARIZATION; THROMBOSIS; THROMBUS ASPIRATION; ATHERECTOMY; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; DRUG ELUTING STENT; FEMORAL ARTERY; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PROCEDURES; TRENDS;

PACLITAXEL;

AGED; ANGIOPLASTY, BALLOON; ATHERECTOMY; DRUG-ELUTING STENTS; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PERIPHERAL ARTERIAL DISEASE;

EID: 85018705464     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.025329     Document Type: Article

References (25)

1. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888. doi: 10.1056/NEJMoa051303.
2. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR; RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267-276. doi: 10.1161/CIRCINTERVENTIONS.109.903468.
3. Krankenberg H, Schlüter M, Steinkamp HJ, Bürgelin K, Scheinert D, Schulte KL, Minar E, Peeters P, Bosiers M, Tepe G, Reimers B, Mahler F, Tübler T, Zeller T. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: The femoral artery stenting trial (FAST). Circulation. 2007;116:285-292. doi: 10.1161/CIRCULATIONAHA. 107.689141.
4. Chowdhury MM, McLain AD, Twine CP. Angioplasty versus bare metal stenting for superficial femoral artery lesions. Cochrane Database Syst Rev. 2014;6:1-49. doi: 10.1002/14651858. CD006767.pub3.
5. Twine CP, Coulston J, Shandall A, McLain AD. Angioplasty versus stenting for superficial femoral artery lesions. Cochrane Database Syst Rev. 2009;2:1-32.doi: 10.1002/14651858.CD006767.pub2.
6. Ruef J. One-year follow-up after implantation of the EverFlex nitinol stent in long lesions of the superficial femoral artery. Angiology. 2009;60:31-35. doi: 10.1177/0003319708317336.
7. Schillinger M, Minar E. Endovascular stent implantation for treatment of peripheral artery disease. Eur J Clin Invest. 2007;37:165-170. doi: 10.1111/j.1365-2362.2007.01774.x.
8. Sabeti S, Czerwenka-Wenkstetten A, Dick P, Schlager O, Amighi J, Mlekusch I, Mlekusch W, Loewe C, Cejna M, Lammer J, Minar E, Schillinger M. Quality of life after balloon angioplasty versus stent implantation in the superficial femoral artery: Findings from a randomized controlled trial. J Endovasc Ther. 2007;14:431-437. doi: 10.1177/152660280701400401.
9. Zeller T, Dake MD, Tepe G, Brechtel K, Noory E, Beschorner U, Kultgen PL, Rastan A. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents. J Am Coll Cardiol. Cardiovasc Interv. 2013;6:274-281. doi: 10.1016/j.jcin.2012.12.118.
10. Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, Hosten N, Hamm B, Speck U, Ricke J. Inhibition of restenosis in femoropopliteal arteries: Paclitaxel-coated versus uncoated balloon: Femoral paclitaxel randomized pilot trial. Circulation. 2008;118:1358-1365. doi: 10.1161/CIRCULATIONAHA. 107.735985.
11. Werk M, Albrecht T, Meyer DR, Ahmed MN, Behne A, Dietz U, Eschenbach G, Hartmann H, Lange C, Schnorr B, Stiepani H, Zoccai GB, Hänninen EL. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: Evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv. 2012;5:831-840. doi: 10.1161/CIRCINTERVENTIONS.112.971630.
12. Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, Metzger C, Scheinert D, Zeller T, Cohen DJ, Snead DB, Alexander B, Landini M, Jaff MR; IN.PACT SFA Trial Investigators. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation. 2015;131:495-502. doi: 10.1161/CIRCULATIONAHA.114.011004.
13. Liistro F, Grotti S, Porto I, Angioli P, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: The DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). J Am Coll Cardiol. Cardiovasc Interv. 2013;6:1295-1302. doi: 10.1016/j.jcin.2013.07.010.
14. Keeling WB, Shames ML, Stone PA, Armstrong PA, Johnson BL, Back MR, Bandyk DF. Plaque excision with the Silverhawk catheter: Early results in patients with claudication or critical limb ischemia. J Vasc Surg. 2007;45:25-31. doi: 10.1016/j.jvs.2006.08.080.
15. Kandzari DE, Kiesz RS, Allie D, Walker C, Fail P, Ramaiah VG, Cardenas J, Vale J, Chopra A, Gammon RS. Procedural and clinical outcomes with catheter-based plaque excision in critical limb ischemia. J Endovasc Ther. 2006;13:12-22. doi: 10.1583/05-1634.1.
16. Zeller T, Rastan A, Sixt S, Schwarzwälder U, Schwarz T, Frank U, Bürgelin K, Müller C, Rothenpieler U, Flügel PC, Tepe G, Neumann FJ. Long-term results after directional atherectomy of femoropopliteal lesions. J Am Coll Cardiol. 2006;48:1573-1578. doi: 10.1016/j.jacc.2006.07.031.
17. Sixt S, Rastan A, Beschorner U, Noory E, Schwarzwälder U, Bürgelin K, Schwarz T, Müller C, Hauk M, Brantner R, Möhrle C, Linnemann B, Macharzina R, Neumann FJ, Zeller T. Acute and long-term outcome of Silverhawk assisted atherectomy for femoro-popliteal lesions according the TASC II classification: A single-center experience. Vasa. 2010;39:229-236. doi: 10.1024/0301-1526/a000034.
18. Diamantopoulos A, Katsanos K. Atherectomy of the femoropopliteal artery: A systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Surg (Torino). 2014;55:655-665.
19. Ibáñez MA, Cenizo N, Rió L, Sánchez A, San Norberto E, Brizuela JA, Gutiérrez V, Vaquero C. Clinical and haemodynamic evolution of lesions treated by means of atherectomy with SilverHawk in the femoropopliteal sector. Eur J Radiol. 2011;80:543-547. doi: 10.1016/j.ejrad.2011.01.018.
20. Beschorner U, Zeller T. Combination of mechanical atherectomy and drug-eluting balloons for femoropopliteal in-stent restenosis. J Cardiovasc Surg (Torino). 2014;55:347-349.
21. Becquemin JP, Favre JP, Marzelle J, Nemoz C, Corsin C, Leizorovicz A. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: A multicenter prospective randomized study. J Vasc Surg. 2003;37:487-494. doi: 10.1067/mva.2003.155.
22. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689-699. doi: 10.1056/NEJMoa0706356.
23. Scheinert D, Schulte KL, Zeller T, Lammer J, Tepe G. Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: Twelve-month results from the BIOLUX P-I randomized trial. J Endovasc Ther. 2015;22:14-21. doi: 10.1177/1526602814564383.
24. Fusaro M, Cassese S, Ndrepepa G, King LA, Tada T, Ott I, Kastrati A. Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: A meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison. Int J Cardiol. 2013;168:4002-4009. doi: 10.1016/j.ijcard.2013.06.081.
25. Cassese S, Byrne RA, Ott I, Ndrepepa G, Nerad M, Kastrati A, Fusaro M. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: A meta-analysis of randomized trials. Circ Cardiovasc Interv. 2012;5:582-589. doi: 10.1161/CIRCINTERVENTIONS. 112.969972.